You searched for "HIV pathogenesis and HIV cure"
3 results found
Professor, Microbiology & Immunology
Harold and Muriel Block Faculty Scholar in Virology
COVID-19, Ebola, and emerging virusesAntibody-based therapiesAnti-viral therapeuticsVirus-host interactions
A recognized expert on emerging viruses, Dr. Chandran studies how viruses infect cells, and his research seeks to translate this knowledge into new antibody-based therapies. In 2020, Dr. Chandran helped lead Einstein’s research on COVID-19: Within weeks of the global outbreak, his laboratory created a “surrogate” coronavirus that allows scientists at Einstein and elsewhere to more safely study the virus. He also helped develop an antibody test for SARS-CoV-2 that is used clinically at Montefiore Health System and by researchers leading a convalescent plasma clinical trial. read more...
Professor, Department of Medicine (Endocrinology)
Jacob A. and Jeanne E. Barkey Chair in Medicine
Chief, Division of Endocrinology
Director, Fleischer Institute for Diabetes and Metabolism
DiabetesType 2 diabetesDiabetes prevention
Clinical TrialsPrediabetesResveratrol
An expert in diabetes prevention, Dr. Crandall is director of the Diabetes Clinical Trials Unit at Einstein and Montefiore and a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE) and the PERL (Preventing Early Renal Loss) study. read more...
Professor, Department of Pediatrics (Pediatric Allergy & Immunology)
Professor, Department of Microbiology & Immunology
Associate Dean for Scientific Resources
Charles Michael Chair in Autoimmune Diseases
Director, Einstein-Rockefeller-CUNY Center for AIDS Research
HIV pathogenesis and HIV cure The immune system's antiviral activityEngineering molecules to attack virusesCAR-T cell structure and function Biologics against cancer and viruses
Dr. Goldstein’s NIH-funded research centers on developing agents to amplify the capacity of the immune system to control HIV infection and achieve a functional cure for the disease. In seeking to “weaponize” the immune system to cure HIV, his lab uses molecular, cellular, and biochemical approaches, including CAR-T cells and the novel treatment strategy developed by Dr. Almo at Einstein for selective T cell amplification called synTac (synthetic T-cell activation). read more...
Tablet Blog